Role of angiotensin-converting enzyme inhibitors in the prevention of atrial fibrillation

American Journal of Cardiology

Volumn 93, Issue 6, 2004, Pages 734-736

  Finkielstein, Dennis ^a   Schweitzer, Paul ^a  

^a BETH ISRAEL MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMIODARONE; ANGIOTENSIN; ANGIOTENSIN RECEPTOR ANTAGONIST; ANTIARRHYTHMIC AGENT; ANTICOAGULANT AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CANDESARTAN; CAPTOPRIL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENALAPRIL; HYDRALAZINE PLUS ISOSORBIDE DINITRATE; IRBESARTAN; ISOSORBIDE MONONITRATE; TRANDOLAPRIL; VASODILATOR AGENT;

ARTICLE; CARDIOVERSION; CLINICAL TRIAL; CONGESTIVE HEART FAILURE; DOSIMETRY; DRUG EFFECT; DRUG MECHANISM; HEART ATRIUM FIBRILLATION; HEART ATRIUM PACING; HEART INFARCTION; HUMAN; NONHUMAN; PRIORITY JOURNAL; REFRACTORY PERIOD;

EID: 1542407824     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjcard.2003.11.073     Document Type: Note

References (12)

1. Kannel W.B., Abbott R.D., Savage D.D., McNamara P.M. Epidemiologic features of atrial fibrillation The Framingham Study. N Engl J Med. 306:1982;1018-1022.
2. Krahn A.D., Manfreda J., Tate R.B., Mathewson F.A., Cuddy T.E. The natural history of atrial fibrillation incidence risk factors, and prognosis in the Manitoba follow-up group. Am J Med. 98:1995;476-484.
3. Wijffels M.C.E.F., Kirchlof C.J.H.J., Dorland R., Allessie M. AF begets AF a study in awake chronically instrumented goats. Circulation. 92:1995;1954-1968.
4. Allessie M.A. Atrial electrophysiological remodeling. Another viscous cycle? J Cardiovasc Electrophysiol. 9:1998;1378-1393.
5. Campbell R.F. ACE inhibitors and arrhythmias. Heart. 76:1996;79-82.
6. Fletcher R.D., Cintron R.B., Johnson G., Orndorff J., Carson P., Cohn J., V-HeFT II VA Cooperative Studies Group. Enalapril decreases the presence of ventricular tachycardia in patients with chronic congestive heart failure. Circulation. 87:(suppl VI):1993;VI-49-VI-55.
7. Pedersen O.D., Bagger H., Kober L., Torp-Pedersen C. Trandolapril reduces the incidence of atrial fibrillation after acute myocardial infarction in patients with left ventricular dysfunction. Circulation. 100:1999;376-380.
8. Tieleman R.G., De Langen C., Van Gelder I.C., de Kam P.J., Grandjean J., Bel K.J., Wijffels M.C., Allessie M.A., Crijns H.J. Verapamil reduces tachycardia-induced electrical remodeling of the atria. Circulation. 95:1997;1945-1953.
9. Nakashima H., Kumagai K., Urata H., Gondo N., Ideishi M., Arakawa K. Angiotensin II antagonist prevents electrical remodeling in atrial fibrillation. Circulation. 101:2000;2612-2617.
10. Li D., Shingawa K., Pang L., Leung T.K., Cardin S., Wang Z., Nattel S. Effects of angiotensin-converting enzyme inhibition on the development of atrial fibrillation substrate in dogs with ventricular tachypacing-induced congestive heart failure. Circulation. 104:2001;2608-2616.
11. Madrid A.H., Bueno M.G., Rebollo J.M., Marin I., Pena G., Bernal E., Rodriguez A., Cano L., Cano J.M., Cabeza P., Moro C. Use of irbesartan to maintain sinus rhythm in patients with long-lasting persistent atrial fibrillation a prospective and randomized study. Circulation. 106:2002;331-336.
12. Vermes E., Tardif J.C., Bourassa M.G., Racine N., Levesque S., White M., Guerra P.G., Ducharme A. Enalapril decreases the incidence of atrial fibrillation in patients with left ventricular dysfunction insight from the Studies Of Left Ventricular Dysfunction (SOLVD) trials. Circulation. 10:2003;2926-2931.